Mark Joseph
Adult Medicine · Brooklyn, NYNPI 1053479816
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,563 of the $2,897 with a category attached, or 88.5%. It is spread thinly across 22 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations.
Across 128 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$405
- AstraZeneca$351
- Lilly USA, LLC$300
- Exact Sciences$242
- Baxter Healthcare$233
- Johnson & Johnson$209
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,56388%
- Education$1003%
- Other$2338%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $405 |
| AstraZeneca | 18 | $351 |
| Lilly USA, LLC | 17 | $300 |
| Exact Sciences | 9 | $242 |
| Baxter Healthcare | 1 | $233 |
| Johnson & Johnson | 9 | $209 |
| Amgen | 8 | $193 |
| Merck | 11 | $173 |
| Amarin Pharma, Inc. | 7 | $150 |
| Boehringer Ingelheim | 5 | $96 |
| Astellas Pharma US Inc | 1 | $94 |
| Kowa Pharmaceuticals America, Inc. | 6 | $88 |
| GSK | 4 | $84 |
| AbbVie(2 entities) | 4 | $75 |
| Mylan Specialty L.p. | 2 | $55 |
| Arbor Pharmaceuticals, Inc. | 2 | $39 |
| Bayer | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Pfizer | 1 | $16 |
| Phadia US Inc. | 1 | $15 |
| Medtronic | 1 | $12 |
How this compares
$2,897 in reported general payments places this provider in the 80th percentile of 101 adult medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 96 | $132,261 |
| JardianceEmpagliflozin | 75 | $71,683 |
| JanuviaSitagliptin Phosphate | 50 | $53,673 |
| MounjaroTirzepatide | 42 | $48,610 |
| FarxigaDapagliflozin Propanediol | 28 | $42,646 |
| TrulicityDulaglutide | 35 | $38,867 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $32,836 |
| JanumetSitagliptin Phos/Metformin Hcl | 27 | $30,768 |
| EliquisApixaban | 21 | $25,537 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $25,298 |
| LinzessLinaclotide | 24 | $21,921 |
| XareltoRivaroxaban | 27 | $19,521 |
| MyrbetriqMirabegron | 18 | $17,311 |
| LyricaPregabalin | 18 | $14,658 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 33 | $9,358 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $405 | $132,26196 claims |
| Lilly USA, LLCMounjaro, Trulicity | $300 | $87,47677 claims |
| MerckJanuvia, Janumet | $173 | $84,44177 claims |
| Boehringer IngelheimJardiance | $96 | $71,68375 claims |
| AstraZenecaFarxiga, Crestor | $351 | $49,84241 claims |
| PfizerEliquis, Lyrica | $16 | $40,19639 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $84 | $39,71541 claims |
| AbbVieLinzess, Synthroid | $75 | $28,325100 claims |
| Johnson & JohnsonXarelto | $209 | $19,52127 claims |
| Astellas Pharma US IncMyrbetriq | $94 | $17,31118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 101 adult medicine providers in New York.
Other adult medicine in Brooklyn
- Cary DanielBrooklyn$10K
- Simon LiBrooklyn$7K
- Donna YuBrooklyn$5K
- Michael PatinBrooklyn$3K
- Keisha SinhaBrooklyn$3K
- Nirmala PatelBrooklyn$2K
- Jennifer CampoverdeBrooklyn$2K
- Claudia Rivera-GalindoBrooklyn$1K
- Michael AlaimoMalverne$18K
- Vipin OhriWarsaw$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.